ArticleMedicine2025

Identification of MMEL1 as a novel therapeutic target for primary sclerosing cholangitis: Integrating Mendelian randomization and transcriptome landscapes.

Chang-Lei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.